Literature DB >> 4183247

Phenobarbitone therapy in neonatal hyperbilirubinaemia.

C Y Yeung, C E Field.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4183247     DOI: 10.1016/s0140-6736(69)92443-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Glucose-6-phosphate dehydrogenase deficiency: a preventable cause of mental retardation.

Authors:  T F Fok; S P Lau
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-22

Review 2.  Recent progress in epilepsy. Diagnostic procedures and treatment.

Authors:  B R Tharp
Journal:  Calif Med       Date:  1973-07

3.  Relative roles of phototherapy and phenobarbitone in treatment of nonhaemolytic neonatal jaundice.

Authors:  Y K Wong; B S Wood
Journal:  Arch Dis Child       Date:  1973-09       Impact factor: 3.791

4.  [Some disorders of blood sugar metabolism in newborn infants].

Authors:  C Y Yeung
Journal:  Acta Diabetol Lat       Date:  1972 Jul-Aug

5.  Sequential trial of effect of phenobarbitone on serum bilirubin of preterm infants.

Authors:  F Carswell; M M Kerr; I R Dunsmore
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

6.  Albumin in management of neonatal hyperbilirubinaemia.

Authors:  Y C Tsao; V Y Yu
Journal:  Arch Dis Child       Date:  1972-04       Impact factor: 3.791

7.  Blood sugar changes in neonatal hyperbilirubinaemia and phenobarbitone therapy.

Authors:  C Y Yeung
Journal:  Arch Dis Child       Date:  1972-04       Impact factor: 3.791

8.  Phenobarbitone in neonatal jaundice.

Authors:  D Sinniah; L K Tay; A E Dugdale
Journal:  Arch Dis Child       Date:  1971-10       Impact factor: 3.791

9.  [Changes in the velocity of drug catabolism and their importance in drug therapy].

Authors:  G F Kahl
Journal:  Klin Wochenschr       Date:  1971-04-01

10.  Successful long-term phenobarbital therapy of hyperbilirubinemia in congenital hemolytic anemia due to glucose phosphate isomerase deficiency.

Authors:  W Schröter
Journal:  Eur J Pediatr       Date:  1980-10       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.